Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is spreading as a pandemic in 2020. Few reports on infections in thoracic transplantation have been published so far. We present a case of COVID-19 in a 55-year old female lung transplant recipient infected 5 months posttransplant, who additionally was co-infected with a Norovirus. Respiratory and gastrointestinal symptoms were observed without need of therapeutic escalation except for antibiotic therapy. We observed a moderate disease evolution likely due to triple immunosuppression
History of heart transplantation in combination with immunosuppressive therapy and acute viral respi...
Solid organ transplantation is often lifesaving, but does carry an increased risk of infection. Resp...
Viral infections account for up to 30% of all infectious complications in lung transplant recipients...
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SA...
Introduction: In 2019, new Coronavirus (SARS-CoV-2) has spread around the globe. The virus can repli...
Several case reports and small case series have been published on coronavirus disease 2019 infection...
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) typically targets the respiratory syste...
Background: With new variants challenging the effectiveness of preventive measures, we are beginning...
Lung transplant recipients (LTRs) are at increased risk for coronavirus disease 2019 (COVID-19)-asso...
We report clinical features, treatments and outcomes in 18 lung transplant recipients with laborator...
International audienceCOVID-19 is a novel infectious disease caused by SARS-CoV-2 that emerged in la...
Allograft infections post lung transplantation have a significant impact on morbidity and mortality....
Coronavirus disease 2019 (COVID-19) has been declared pandemic since March 2020. In Europe, Italy ha...
Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the ...
Lung transplant recipients present an increased risk for severe complications associated with respir...
History of heart transplantation in combination with immunosuppressive therapy and acute viral respi...
Solid organ transplantation is often lifesaving, but does carry an increased risk of infection. Resp...
Viral infections account for up to 30% of all infectious complications in lung transplant recipients...
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SA...
Introduction: In 2019, new Coronavirus (SARS-CoV-2) has spread around the globe. The virus can repli...
Several case reports and small case series have been published on coronavirus disease 2019 infection...
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) typically targets the respiratory syste...
Background: With new variants challenging the effectiveness of preventive measures, we are beginning...
Lung transplant recipients (LTRs) are at increased risk for coronavirus disease 2019 (COVID-19)-asso...
We report clinical features, treatments and outcomes in 18 lung transplant recipients with laborator...
International audienceCOVID-19 is a novel infectious disease caused by SARS-CoV-2 that emerged in la...
Allograft infections post lung transplantation have a significant impact on morbidity and mortality....
Coronavirus disease 2019 (COVID-19) has been declared pandemic since March 2020. In Europe, Italy ha...
Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the ...
Lung transplant recipients present an increased risk for severe complications associated with respir...
History of heart transplantation in combination with immunosuppressive therapy and acute viral respi...
Solid organ transplantation is often lifesaving, but does carry an increased risk of infection. Resp...
Viral infections account for up to 30% of all infectious complications in lung transplant recipients...